TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 4 |
| P | %wins | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/17 21:39 | 9/25/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jenkinson Paul L | CA | O | CFO | S | -170 | 179.66 | 0 | -1 | -7 | 12 | D | ||||||||||||||
5/10/17 15:12 | 5/10/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jenkinson Paul L | CA | O | CFO | P | 250 | 72.59 | 33 | 3 | 49 | 10 | M | 28 | 57 | 69 | 36 | -8 | -9 | -12 | -14 | 4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |